Boundless Bio, Inc. BOLD
2.66
0.06
2.31%
as of 25 Sep
- Market cap
- $59.1M
- P/E
- 0.0×
Follow BOLD
Insider Buys
alert about insiders buying in the last 12 month
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
Current Ratio |
+8 more quarters Free account |
10.14 | 8.74 | 9.87 | 9.48 |
Net Debt/EBITDA |
4.78 | 4.51 | 3.37 | 3.14 | |
Debt/Assets |
27.68% | 29.20% | 31.92% | 0.00% | |
Debt/Equity |
0.42 | 0.46 | 0.52 | 0.00 | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.73 | 0.78 | 1.10 | 0.89 | |
Capex/Depreciation |
(0.05) | (1.38) | (0.03) | (0.03) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Free Cash Flow per Share |
(0.46) | (0.47) | (0.67) | (0.94) | |
Cash per Share |
5.25 | 4.81 | 4.14 | 3.24 | |
Shareholders Equity per Share |
4.92 | 4.41 | 3.86 | 2.94 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
4.92 | 4.41 | 3.86 | 2.94 | |
Free Cash Flow |
(10.21) | (10.53) | (14.98) | (21.01) | |
Working Capital |
108.31 | 97.07 | 85.03 | 65.88 | |
Capital Expenditures |
(0.01) | (0.42) | (0.01) | (0.04) | |
Net Current Asset Value |
61.60 | 51.21 | 40.03 | 65.88 | |
| Other line items | |||||
Quick Ratio |
9.93 | 8.58 | 9.69 | 9.35 | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(0.46) | (0.45) | (0.67) | (0.93) | |
Capex per Share |
0.00 | (0.02) | 0.00 | 0.00 | |
Average Payables |
6.91 | 6.04 | 5.33 | 5.43 | |
Average Assets |
171.91 | 181.73 | 166.11 | 126.60 | |
Average Common Equity |
137.63 | 124.65 | 111.49 | 94.33 | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% |
Columns are period end dates